-
-
-
-
-
-
-
H.C. Wainwright on Senti Biosciences, Inc. (SNTI): FDA Alignment and Mid-2026 Durability Data in Focus
-
-
-
-
-
-
-
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
-
-
-
-
-
-
-
Senti Biosciences (SNTI) Joins Webull Corporate Connect Service Platform
-
-
-
-
-
-
-
Senti Biosciences (SNTI) Halted on Volatility, Now Up 493%
-
-
-
-
-
-
-
Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits
433,992 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

